Alzheimer's disease (AD) and mild cognitive impairment (MCI) are neurodegenerative conditions that affect the aging population worldwide. Neuroimaging and neurostimulation techniques have gained increasing attention in recent years as valuable tools for early detection and treatment of these conditions.
This Research Topic aims to provide a comprehensive overview of the latest advances in this field. We welcome original research, case reports, and reviews that address topics such as structural and functional brain changes associated with AD and MCI, methods for detecting early signs of cognitive decline using neuroimaging, and the potential of non-invasive neurostimulation techniques for treating these conditions. Manuscripts that focus on the application of neuroimaging techniques such as MRI, fMRI, EEG, DWI, MEG, or PET, and invasive or non-invasive stimulation techniques such as DBS, tDCS, and TMS are highly encouraged.
Topics of interest for this article collection include, but are not limited to:
• The use of neuroimaging techniques (such as fMRI, DTI, MEG, EEG, PET, etc.) to detect early signs of cognitive decline in AD and MCI patients
• The application of neuroimaging techniques to better understand the structural and functional brain changes associated with AD and MCI
• The use of invasive and non-invasive neurostimulation techniques (such as TMS, tDCS, DBS, etc.) for the treatment of AD and MCI patients
• Comparative studies of different neuroimaging and neurostimulation techniques to identify the most effective and efficient ones for detecting and treating AD and MCI
• Identification of biomarkers using neuroimaging techniques for predicting the progression and severity of AD and MCI
• The role of artificial intelligence and machine learning techniques in analyzing neuroimaging data for detecting and treating AD and MCI
We aim to present a collection that provides novel insights into the early detection and treatment of AD and MCI and contribute to the development of new therapies that can improve the quality of life of affected individuals.
Alzheimer's disease (AD) and mild cognitive impairment (MCI) are neurodegenerative conditions that affect the aging population worldwide. Neuroimaging and neurostimulation techniques have gained increasing attention in recent years as valuable tools for early detection and treatment of these conditions.
This Research Topic aims to provide a comprehensive overview of the latest advances in this field. We welcome original research, case reports, and reviews that address topics such as structural and functional brain changes associated with AD and MCI, methods for detecting early signs of cognitive decline using neuroimaging, and the potential of non-invasive neurostimulation techniques for treating these conditions. Manuscripts that focus on the application of neuroimaging techniques such as MRI, fMRI, EEG, DWI, MEG, or PET, and invasive or non-invasive stimulation techniques such as DBS, tDCS, and TMS are highly encouraged.
Topics of interest for this article collection include, but are not limited to:
• The use of neuroimaging techniques (such as fMRI, DTI, MEG, EEG, PET, etc.) to detect early signs of cognitive decline in AD and MCI patients
• The application of neuroimaging techniques to better understand the structural and functional brain changes associated with AD and MCI
• The use of invasive and non-invasive neurostimulation techniques (such as TMS, tDCS, DBS, etc.) for the treatment of AD and MCI patients
• Comparative studies of different neuroimaging and neurostimulation techniques to identify the most effective and efficient ones for detecting and treating AD and MCI
• Identification of biomarkers using neuroimaging techniques for predicting the progression and severity of AD and MCI
• The role of artificial intelligence and machine learning techniques in analyzing neuroimaging data for detecting and treating AD and MCI
We aim to present a collection that provides novel insights into the early detection and treatment of AD and MCI and contribute to the development of new therapies that can improve the quality of life of affected individuals.
